Mycoses

Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT

Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease

Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)

Bioequivalence Study for Terbinafine 250 mg

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)

Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome

Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)

Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)

Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)